Furthermore, FEZF1-AS1, which promotes cell proliferation and inhibits apoptosis, is found to be overexpressed in placental tissues collected from preeclampsia patients and in various tumors, predicting a poor outcome [43,44]. Here, FEZF1 is linked to preeclampsia.